Adenoviruses Using the Cancer Marker EphA2 as a Receptor In Vitro and In Vivo by Genetic Ligand Insertion into Different Capsid Scaffolds

• Michael Behr,

  Current address: Dr. von Froreich Bioscientia Medical Laboratory, Hamburg, Germany

  Affiliation Oncolytic Adenovirus Group, German Cancer Research Center (DKFZ), Heidelberg, Germany

  ⨯
• Johanna K. Kaufmann,

  Current address: Harvey Cushing Neuro-Oncology Laboratories, Department of Neurosurgery, Brigham & Women's Hospital and Harvard Medical School, Boston, Massachusetts, United States of America

  Affiliation Oncolytic Adenovirus Group, German Cancer Research Center (DKFZ), Heidelberg, Germany

  ⨯
• Patrick Ketzer,

  Affiliation Oncolytic Adenovirus Group, German Cancer Research Center (DKFZ), Heidelberg, Germany

  ⨯
• Sarah Engelhardt,

  Affiliation Oncolytic Adenovirus Group, German Cancer Research Center (DKFZ), Heidelberg, Germany

  ⨯
• Martin Mück-Häusl,

  Current address: Institute of Virology, Helmholtz Center Munich, Munich, Germany

  Affiliation Max von Pettenkofer-Institute, Department of Virology, Ludwig-Maximilians-University Munich, Munich, Germany

  ⨯
• Pamela M. Okun,

  Affiliation Department of General Pediatrics, Division of Inherited Metabolic Diseases, Heidelberg University Hospital, Heidelberg, Germany

  ⨯
• Gabriele Petersen,

  Affiliation COS, CellNetworks Deep Sequencing Core Facility, University Heidelberg, Heidelberg, Germany

  ⨯
• Frank Neipel,

  Affiliation Institute for Clinical and Molecular Virology, Erlangen University Hospital, Erlangen, Germany

  ⨯
• Jessica C. Hassel,

  Affiliation Department of Dermatology, Heidelberg University Hospital, Heidelberg, Germany

  ⨯
• Anja Ehrhardt,

  Affiliations Max von Pettenkofer-Institute, Department of Virology, Ludwig-Maximilians-University Munich, Munich, Germany, Institute of Virology and Microbiology, Center for Biomedical Education and Research, Department of Human Medicine, Faculty of Health, University Witten/Herdecke, Witten, Germany

  ⨯
• Alexander H. Enk,

  Affiliation Department of Dermatology, Heidelberg University Hospital, Heidelberg, Germany

  ⨯
• Dirk M. Nettelbeck

  * E-mail: d.nettelbeck@dkfz.de

  Affiliation Oncolytic Adenovirus Group, German Cancer Research Center (DKFZ), Heidelberg, Germany

  ⨯